You must log in to view this page.

Fate Therapeutics Inc. – Ownership Summary

NASDAQ: FATE
Share price (5/22/26): $2.25
Market cap (5/22/26): $262 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Google Finance
SEC EDGAR

Insider Ownership

Tahl Cindy »

12/34/56

144

12/34/56

Valamehr Bahram »

12/34/56

144

12/34/56

144

12/34/56

≥5% Ownership

Vanguard Group Inc »

SCHEDULE 13G/A

SCHEDULE 13G/A

SC 13G/A

SC 13G/A

SC 13G/A

Mendlein John »

144

12/34/56

Fate Therapeutics Inc. – Ownership Summary Watch

Search in Documents

Key Exhibits

External Links

Insider Ownership

Tahl Cindy »

Valamehr Bahram »

≥5% Ownership

Vanguard Group Inc »

Mendlein John »

Fate Therapeutics Inc. – Ownership Summary